Pharmacokinetics of Antiretroviral Drugs in Older People Living with HIV, Part II: Drugs Licensed Before 2005.
Saved in:
| Title: | Pharmacokinetics of Antiretroviral Drugs in Older People Living with HIV, Part II: Drugs Licensed Before 2005. |
|---|---|
| Authors: | Toledo T; Sérgio Arouca National School of Public Health ENSP Fiocruz, Rio de Janeiro, RJ, Brazil., Oliveira VG; Evandro Chagas National Institute of Infectious Diseases INI Fiocruz, Rio de Janeiro, Brazil., Cattani VB; Evandro Chagas National Institute of Infectious Diseases INI Fiocruz, Rio de Janeiro, Brazil., Seba K; Faculty of Pharmacy, Fluminense Federal University, Rio de Janeiro, Brazil., Veloso VG; Evandro Chagas National Institute of Infectious Diseases INI Fiocruz, Rio de Janeiro, Brazil., Grinsztejn B; Evandro Chagas National Institute of Infectious Diseases INI Fiocruz, Rio de Janeiro, Brazil., Cardoso SW; Evandro Chagas National Institute of Infectious Diseases INI Fiocruz, Rio de Janeiro, Brazil., Torres TS; Evandro Chagas National Institute of Infectious Diseases INI Fiocruz, Rio de Janeiro, Brazil., Estrela R; Sérgio Arouca National School of Public Health ENSP Fiocruz, Rio de Janeiro, RJ, Brazil. rita.estrela@ini.fiocruz.br.; Evandro Chagas National Institute of Infectious Diseases INI Fiocruz, Rio de Janeiro, Brazil. rita.estrela@ini.fiocruz.br.; Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. rita.estrela@ini.fiocruz.br. |
| Source: | Clinical pharmacokinetics [Clin Pharmacokinet] 2024 Dec; Vol. 63 (12), pp. 1655-1666. Date of Electronic Publication: 2024 Nov 14. |
| Publication Type: | Journal Article; Systematic Review |
| Journal Info: | Publisher: Adis, part of Springer Science+Business Media Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1926 (Electronic) Linking ISSN: 03125963 NLM ISO Abbreviation: Clin Pharmacokinet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
